Crescent Biopharma (CBIO) Research & Development (2013 - 2026)
Crescent Biopharma (CBIO) posted Research & Development of $19.39 million for Q2 2026, up 60.5% from $12.08 million a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Research & Development (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Crescent Biopharma was $152.67 million, up 297.0% year-over-year; for FY2025, it came in at $138.09 million, up 868.4% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 25.2% (FY2020 to FY2025).
- In prior years, Crescent Biopharma's Research & Development was $14.26 million in FY2024 (-29.0%), $20.07 million in FY2023 (-29.3%), $28.39 million in FY2022 (-40.2%) and $47.49 million in FY2021 (+5.7%).
- Quarterly Research & Development has run from a low of $1.72 million in Q3 2024 to a high of $95.03 million in Q4 2025 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last three quarters, with growth averaging 138.9% over the last seven quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2025, with growth of 577.1%; the weakest was Q3 2024, with a decline of 67.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $17.9 million (Q1 2026), $95.03 million (Q4 2025) and $20.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | 19.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.39 Mn |
| Mar 31, 2026 | 17.90 Mn |
| Dec 31, 2025 | 95.03 Mn |
| Sep 30, 2025 | 20.35 Mn |
| Jun 30, 2025 | 12.08 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 14.03 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 6.29 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 5.29 Mn |
| Jun 30, 2023 | 4.07 Mn |
| Mar 31, 2023 | 5.42 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 4.92 Mn |
| Jun 30, 2022 | 7.97 Mn |
| Mar 31, 2022 | 9.60 Mn |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 13.28 Mn |
API Access
Crescent Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();